Events & Presentations

Upcoming Events

View all
SaxoCell Conference on Cell and Gene Therapy

SaxoCell Conference on Cell and Gene Therapy

Tue 02 Jun 2026

Explore the Future of Cell and Gene Therapy Development hVIVO will be attending the SaxoCell Conference, a focused ...

Early Phase, Clinical Consulting, Cell & Gene Therapy Dresden, Germany
View
11th German Pharm-Tox Summit 2026

11th German Pharm-Tox Summit 2026

Sat 13 Jun 2026

The GPTS is organized by the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT). The ...

CRS, Scientific Düsseldorf, Germany
View
BIO International Convention

BIO International Convention

Mon 22 Jun 2026

hVIVO is proud to be attending BIO International Convention 2026, the world’s largest gathering of biotechnology, ...

San Diego
View
World Vaccine Congress Europe

World Vaccine Congress Europe

Mon 19 Oct 2026

Accelerate Vaccine Development Through Collaboration and Innovation hVIVO will be attending the World Vaccine Congress ...

Early Phase, Clinical Consulting, Infectious Diseases Amsterdam, Netherlands
View
BIO-Europe 2026

BIO-Europe 2026

Mon 09 Nov 2026

Connect with the Right Partners to Accelerate Biopharma Growth hVIVO will be attending BIO-Europe, the leading ...

Early Phase, Clinical Consulting, Biotech Cologne, Germany
View
Dutch Life Sciences Conference 2026

Dutch Life Sciences Conference 2026

Thu 26 Nov 2026

Connect with Europe’s Leading Life Sciences Ecosystem hVIVO will be attending the Dutch Life Sciences Conference, a key ...

Early Phase, Clinical Consulting, Biotech Leiden Bioscience Park, The Netherlands
View

    Past Presentations

    Capital Markets Day – July 2024

    17 July 2024
    Capital Markets Day 2024

    Sign in to watch below, or download slides.

    Past Presentations

    View all
    29 Jan 2026 36 mins

    Trading Update FY25

    HVIVO plc (HVO:AIM) reported an unaudited FY25 trading update highlighting resilient company performance amid a challenging macro backdrop, with revenue of £46.7 million in line with revised guidance and a positive low single-digit adjusted EBITDA margin, outperforming market expectations.

    Download PDF
    23 Sep 2025 42 mins

    HVIVO PLC - Interim Results

    Welcome to the HVO PLC interim results investor presentation.

    Download PDF
    22 Jul 2025 37 mins

    H1 25 Trading Update

    hVIVO's first half 2025 trading update, presented by Yamin Khan

    Download PDF
    10 Apr 2025 55 mins

    Full Year Results 2024

    Financial performance was a record year for hVIVO and also a transformational one for operations.

    Download PDF

    Investor Quick Links

    Regulatory News

    Learn more

    Presentations & Events

    Learn more 

    Environmental, Social & Governance

    Learn more 

    Share Price Information

    Learn more 

    AIM Rule 26

    Learn more 

    Media Library

    Learn more 

    Contact our Investor Relations team.

    IR@hvivo.com